Kazia Therapeutics Limited (KZIA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KZIA Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Kazia Therapeutics Limited's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
0 0 0 (Jun 30 2024)
Assets
Cash And Cash Equivalents4.35
Cash & Short-term Investments4.00
Other Current Assets0.59
Total Current Assets4.93
Intangible Assets0.00
Other Assets, Noncurrent1.13
Total Assets6.06
Liabilities
Accounts Payable0.00
Shortterm Borrowings0.40
Other Liabilities, Current13.66
Total Current Liabilities14.05
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.27
Other liabilities, Noncurrent0.04
Total Liabilities14.36
Stockholders' Equity
Common Stockholder's Equity-8.30
Total Stockholder's Equity-8.30
Liabilities & Stockholder's Equity6.06
4 historic quarters locked

Sign in to unlock the full Kazia Therapeutics Limited balance sheet history.

About Kazia Therapeutics Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20250630)
  • Filed with the SEC: November 7, 2025
  • Source: d908386d20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-272284

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.